Mass Spectrometry-Based Omics for the Characterization of Triple-Negative Breast Cancer Bio-Signature

Mass Spectrometry-Based Omics for the Characterization of Triple-Negative Breast Cancer Bio-Signature

Triple-negative breast cancer (TNBC) represents an unmet medical need due to a high rate of metastatic occurrence and poor overall survival, pathology aggressiveness, heterogeneous clinical behavior and limited cytotoxic chemotherapy options available because of the absence of targetable receptors....

Full description

Bibliographic Details
Main Authors: Ioana-Ecaterina Pralea, Radu-Cristian Moldovan, Adrian-Bogdan Țigu, Corina Ionescu, Cristina-Adela Iuga
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Journal of Personalized Medicine
Subjects:
TNBC
mass spectrometry
omics
metabolomics
proteomics
lipidomics
Online Access:https://www.mdpi.com/2075-4426/10/4/277

Similar Items

Similar Items